Postinfectious vasculitis

disease
On this page

Summary

Postinfectious vasculitis (MONDO:0018837) is a disease. A subtype of secondary vasculitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: Unknown (Worldwide)
  • Phenotypes (HPO): 57

Clinical features

Signs & symptoms

Clinical features (HPO)

57 HPO clinical features (Orphanet curated; top 50 by frequency):

HPO IDTermFrequency
HP:0000099GlomerulonephritisFrequent (30-79%)
HP:0001824Weight lossFrequent (30-79%)
HP:0001945FeverFrequent (30-79%)
HP:0002039AnorexiaFrequent (30-79%)
HP:0002829ArthralgiaFrequent (30-79%)
HP:0003326MyalgiaFrequent (30-79%)
HP:0005368Abnormality of humoral immunityFrequent (30-79%)
HP:0010876Abnormal circulating protein levelFrequent (30-79%)
HP:0011123Inflammatory abnormality of the skinFrequent (30-79%)
HP:0011227Elevated circulating C-reactive protein concentrationFrequent (30-79%)
HP:0012649Increased inflammatory responseFrequent (30-79%)
HP:0030166Night sweatsFrequent (30-79%)
HP:0031691Severe viral infectionFrequent (30-79%)
HP:0032018Multiple mononeuropathyFrequent (30-79%)
HP:0200029Vasculitis in the skinFrequent (30-79%)
HP:0410008Abnormality of the peripheral nervous systemFrequent (30-79%)
HP:0000093ProteinuriaOccasional (5-29%)
HP:0000790HematuriaOccasional (5-29%)
HP:0000793Membranoproliferative glomerulonephritisOccasional (5-29%)
HP:0000822HypertensionOccasional (5-29%)
HP:0000965Cutis marmorataOccasional (5-29%)
HP:0001063AcrocyanosisOccasional (5-29%)
HP:0001369ArthritisOccasional (5-29%)
HP:0001482Subcutaneous noduleOccasional (5-29%)
HP:0001638CardiomyopathyOccasional (5-29%)
HP:0002011Morphological central nervous system abnormalityOccasional (5-29%)
HP:0002027Abdominal painOccasional (5-29%)
HP:0002090PneumoniaOccasional (5-29%)
HP:0002140Ischemic strokeOccasional (5-29%)
HP:0002617DilatationOccasional (5-29%)
HP:0002726Recurrent Staphylococcus aureus infectionsOccasional (5-29%)
HP:0002923Rheumatoid factor positiveOccasional (5-29%)
HP:0003261Increased circulating IgA levelOccasional (5-29%)
HP:0003493Antinuclear antibody positivityOccasional (5-29%)
HP:0004386Gastrointestinal inflammationOccasional (5-29%)
HP:0005318Cerebral vasculitisOccasional (5-29%)
HP:0005366Recurrent streptococcus pneumoniae infectionsOccasional (5-29%)
HP:0005401Recurrent candida infectionsOccasional (5-29%)
HP:0006562Viral hepatitisOccasional (5-29%)
HP:0006689Bacterial endocarditisOccasional (5-29%)
HP:0009830Peripheral neuropathyOccasional (5-29%)
HP:0010702Increased circulating antibody levelOccasional (5-29%)
HP:0011274Recurrent mycobacterial infectionsOccasional (5-29%)
HP:0020101Invasive fungal infectionOccasional (5-29%)
HP:0020114Persistent human papillomavirus infectionOccasional (5-29%)
HP:0020180Elevated haptoglobin levelOccasional (5-29%)
HP:0025143ChillsOccasional (5-29%)
HP:0025188Retinal vasculitisOccasional (5-29%)
HP:0030880Raynaud phenomenonOccasional (5-29%)
HP:0031363Palpable purpuraOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical namepostinfectious vasculitis
Mondo IDMONDO:0018837
Orphanet48435
SNOMED CT724063005
UMLSC4510302
MedGen1376009
GARD0018835
Is cancer (heuristic)no

Disease family

This is a subtype of secondary vasculitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › cardiovascular disordervascular disordervasculitissecondary vasculitispostinfectious vasculitis

Related subtypes (1): drug-induced vasculitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.